96 related articles for article (PubMed ID: 23624388)
1. Prophylactic effect of a peptide vaccine targeting TM4SF5 against colon cancer in a mouse model.
Kwon S; Kim YE; Kim D; Park BK; Wu G; Kim TH; Choi SH; Kim DS; Kwon HJ; Lee Y
Biochem Biophys Res Commun; 2013 May; 435(1):134-9. PubMed ID: 23624388
[TBL] [Abstract][Full Text] [Related]
2. Induction of immunological memory response by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex in a mouse hepatocellular carcinoma model.
Kwon S; Kim D; Park BK; Wu G; Park MC; Ha YW; Kwon HJ; Lee Y
Oncol Rep; 2013 Feb; 29(2):735-40. PubMed ID: 23138455
[TBL] [Abstract][Full Text] [Related]
3. Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model.
Wu G; Kim D; Park BK; Park S; Ha JH; Kim TH; Gautam A; Kim JN; Lee SI; Park HB; Kim YS; Kwon HJ; Lee Y
Oncotarget; 2016 Nov; 7(48):79170-79186. PubMed ID: 27816969
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of a TM4SF5-specific peptide vaccine against colon cancer in a mouse model.
Kwon S; Kim YE; Park JA; Kim DS; Kwon HJ; Lee Y
BMB Rep; 2014 Apr; 47(4):215-20. PubMed ID: 24286311
[TBL] [Abstract][Full Text] [Related]
5. Production of an anti-TM4SF5 monoclonal antibody and its application in the detection of TM4SF5 as a possible marker of a poor prognosis in colorectal cancer.
Park BK; Park JY; Kim TH; Kim D; Wu G; Gautam A; Maharjan S; Lee SI; Lee Y; Kwon HJ; Choi KC
Int J Oncol; 2018 Jul; 53(1):275-285. PubMed ID: 29749436
[TBL] [Abstract][Full Text] [Related]
6. Prevention and therapy of hepatocellular carcinoma by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex without carriers.
Kwon S; Kim D; Park BK; Cho S; Kim KD; Kim YE; Park CS; Ahn HJ; Seo JN; Choi KC; Kim DS; Lee Y; Kwon HJ
PLoS One; 2012; 7(3):e33121. PubMed ID: 22427965
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model.
Kim YE; Kwon S; Wu G; Kim D; Park BK; Park JA; Choi KC; Kim DS; Kwon HJ; Lee Y
Oncotarget; 2014 Sep; 5(18):8402-15. PubMed ID: 25268742
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody targeting of the cell surface molecule TM4SF5 inhibits the growth of hepatocellular carcinoma.
Kwon S; Choi KC; Kim YE; Ha YW; Kim D; Park BK; Wu G; Kim DS; Lee Y; Kwon HJ
Cancer Res; 2014 Jul; 74(14):3844-56. PubMed ID: 24802189
[TBL] [Abstract][Full Text] [Related]
9. A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model.
Park S; Kim D; Wu G; Jung H; Park JA; Kwon HJ; Lee Y
Onco Targets Ther; 2018; 11():8655-8672. PubMed ID: 30584324
[TBL] [Abstract][Full Text] [Related]
10. Peptide vaccine induces enhanced tumor growth associated with apoptosis induction in CD8+ T cells.
Muraoka D; Kato T; Wang L; Maeda Y; Noguchi T; Harada N; Takeda K; Yagita H; Guillaume P; Luescher I; Old LJ; Shiku H; Nishikawa H
J Immunol; 2010 Sep; 185(6):3768-76. PubMed ID: 20733202
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines.
Yamaguchi S; Tatsumi T; Takehara T; Sakamori R; Uemura A; Mizushima T; Ohkawa K; Storkus WJ; Hayashi N
Cancer; 2007 Oct; 110(7):1469-77. PubMed ID: 17685394
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity.
Ahn HM; Ryu J; Song JM; Lee Y; Kim HJ; Ko D; Choi I; Kim SJ; Lee JW; Kim S
Theranostics; 2017; 7(3):594-613. PubMed ID: 28255353
[TBL] [Abstract][Full Text] [Related]
13. Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis.
Lee SA; Kim TY; Kwak TK; Kim H; Kim S; Lee HJ; Kim SH; Park KH; Kim HJ; Cho M; Lee JW
J Cell Biochem; 2010 Sep; 111(1):59-66. PubMed ID: 20506553
[TBL] [Abstract][Full Text] [Related]
14. [A DNA vaccine encoding the extracellular domain of porcine endoglin induces antitumor immunity in a mouse colon carcinoma model].
Jiao JG; Zhang YD; Li YN
Ai Zheng; 2005 Oct; 24(10):1179-83. PubMed ID: 16219129
[TBL] [Abstract][Full Text] [Related]
15. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.
Lee SA; Ryu HW; Kim YM; Choi S; Lee MJ; Kwak TK; Kim HJ; Cho M; Park KH; Lee JW
Hepatology; 2009 Apr; 49(4):1316-25. PubMed ID: 19177595
[TBL] [Abstract][Full Text] [Related]
16. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
Bolesta E; Kowalczyk A; Wierzbicki A; Rotkiewicz P; Bambach B; Tsao CY; Horwacik I; Kolinski A; Rokita H; Brecher M; Wang X; Ferrone S; Kozbor D
Cancer Res; 2005 Apr; 65(8):3410-8. PubMed ID: 15833876
[TBL] [Abstract][Full Text] [Related]
18. A novel DNA vaccine encoding PDGFRbeta suppresses growth and dissemination of murine colon, lung and breast carcinoma.
Kaplan CD; Krüger JA; Zhou H; Luo Y; Xiang R; Reisfeld RA
Vaccine; 2006 Nov; 24(47-48):6994-7002. PubMed ID: 17050049
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial therapy for liver metastatic colon cancer: dendritic cell vaccine and low-dose agonistic anti-4-1BB antibody co-stimulatory signal.
Lee H; Park HJ; Sohn HJ; Kim JM; Kim SJ
J Surg Res; 2011 Jul; 169(1):e43-50. PubMed ID: 21571303
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of new HER2 peptide vaccination based on B cell epitope.
Miyako H; Kametani Y; Katano I; Ito R; Tsuda B; Furukawa A; Saito Y; Ishikawa D; Ogino K; Sasaki S; Imai K; Habu S; Makuuchi H; Tokuda Y
Anticancer Res; 2011 Oct; 31(10):3361-8. PubMed ID: 21965747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
